Email Updates

You are here

Home

11 DECEMBER 2020 VOLUME 22 ISSUE 48

Media Coverage

  • Voucher Scheme to Encourage Young South African Women to Take PrEP Has Modest Impact

    A 12-month trial that offered adolescent girls and young women in South Africa shopping vouchers for three months as an incentive to take tenofovir‐based pre‐exposure prophylaxis (PrEP) found it only made a modest difference to longer-term adherence.

    December 9, 2020
    PrEP
    Avert

  • HIV War: Children the Forgotten Lot

    “How’s your grandson?” a nurse asks her at the clinic. The elderly woman from Kosewe, Homa Bay County, does not have a simple answer. She shakes her head in tears. “We’re back in hospital. I’m overwhelmed and I don’t know what to do,” she says in a whisper.

    December 9, 2020
    Treatment
    The Citizen

  • U=U Encourages Men in South Africa to Test for HIV

    As men in sub-Saharan Africa test for HIV less often than women, a team led by Dr Philip Smith of University of Cape Town, South Africa, wanted to know if men would be encouraged to test more when they knew about the U=U message. The team found that when peer promoters told men that an undetectable viral load means that, if they test positive, they cannot pass the virus to sexual partners, they were more likely to go for HIV testing.

    December 9, 2020
    Treatment
    aidsmap

  • HIV Clinical Trials Network Is Restructured to Boost Efficiency

    The national system of HIV clinical trials has been reorganized and refined. Specifically, the new structure divides trials into four distinct networks, each with its own leadership and area of focus. The goal is to increase efficiency, reduce costs and allow researchers not only to work better together but also be able to pivot to emergent infectious diseases, such as COVID-19.

    December 8, 2020
    General
    POZ

  • Getting Gauteng’s HIV and TB Response Back on Track

    From March to July 2020, the Gauteng health department recorded 57,848 TB tests – a decrease of about 30,000 tests compared with the same period in 2019. The province performed better with HIV testing, although the HIV response has faltered in other areas. Spotlight looks at the province’s numbers and speaks to activists and community health workers about the impact of lockdown and plans to get things back on track.

    December 8, 2020
    Treatment
    Daily Maverick

  • Biden’s Choice to Run CDC Is a Respected Specialist Who Is Unafraid to Speak Her Mind

    President-elect Joe Biden’s choice to run the Centers for Disease Control and Prevention is a widely respected infectious-diseases specialist regarded as a strong communicator unafraid to speak her mind, qualities critical to returning the beleaguered public health agency to its traditional front-line role and to bringing the coronavirus pandemic under control.

    December 8, 2020
    Washington Post

  • Treating HIV/AIDS in Uganda

    In the years after the “slim disease” or HIV was first recognised in southwestern Uganda in 1982, access to treatment was for a privileged few. At the time, only a handful of clinics such as the Joint Clinical Research Centre could offer any relief for those living with HIV. Because only a small number of patients could afford the prohibitive fees for HIV services, care was almost entirely provided by medical doctors.

    December 7, 2020
    Treatment
    Independent Uganda

  • Having More Options Makes PrEP More Viable

    The Centers for Disease Control and Prevention recently reported that HIV related deaths declined by 48.4 percent between 2010 and 2018, and that there was a 23 percent decline in seroconversions between 2010 and 2019. Unfortunately, Black people and women continue to make up the bulk of reported deaths and new infections each year.

    December 7, 2020
    PrEP
    The Body

  • 2020 Was a Huge Year for PrEP. Why Don’t Black Men Know About It?

    We have made tremendous progress on HIV prevention and treatment over the years. New cases are down, and people are now living long and healthy lives. However, not everyone is having an equal shot at benefiting from this progress, and that is something that keeps many of us awake at night as we seek solutions to make everyone benefit.

    December 6, 2020
    PrEP
    GQ UK

  • Uganda, Kenya Picked for Flavoured Drug for Children Living With HIV

    Uganda and Kenya are among six African countries set to receive new generic strawberry-flavoured tablets for treating children living with human immunodeficiency virus (HIV) in the first half of 2021.

    December 4, 2020
    Treatment
    Daily Monitor

Published Research

Announcements